Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Baxter buys Aes103 sickle cell program through AesRx takeover

Executive Summary

As it prepares to spin off its biopharma business next year, Baxter International Inc. made another acquisition to build up hemophilia assets, this time buying closely held AesRx LLC (orphan diseases). The transaction included an up-front payment plus development, regulatory, and commercial earn-outs.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Acquisition of Private Biotech
    • Includes Earnout

Related Companies